4NK-24279-11606
3 vaccinations
3 coded responses
27 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 272 / NC
- Registered
- 2021-01-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-03
Registered in v-safe
-
2021-01-03
Dose 1 — Pfizer-BioNTech
- 2021-01-03
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-17
-
2021-01-24
Dose 2 — Pfizer-BioNTech
-
2021-01-24
Survey response — day 0, dose 2MedDRA: Heart rate increased, Paraesthesia oral — Feeling: GoodFree text: 10 minutes after I experienced short episode of rapid heart beat and tongue tingling, both symptoms resolved within a few minutes, without intervention, and have not returnedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-07
- 2021-02-14
-
2021-02-21
Survey response — day 28, dose 2MedDRA: Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: A common cold. Mild congestion and runny nose were the only symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-28
- 2021-03-09
- 2021-04-26
- 2021-07-25
- 2022-01-25
-
2022-03-04
Dose 3 — Pfizer-BioNTech
-
2022-06-03
Survey response — 3 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-09-02
- 2023-03-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-03 | Pfizer-BioNTech | |
| 2 | 2021-01-24 | Pfizer-BioNTech | |
| 3 | 2022-03-04 | Pfizer-BioNTech | No |
Free text
Release 2 — day 0, dose 2
Systemic reaction (other): 10 minutes after I experienced short episode of rapid heart beat and tongue tingling, both symptoms resolved within a few minutes, without intervention, and have not returned
Release 4 — day 28, dose 2
Symptoms: A common cold. Mild congestion and runny nose were the only symptoms.
Release 11 — 3 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Paraesthesia oral | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release